| Literature DB >> 34536095 |
Sebastian Gnat1, Dominik Łagowski2, Mariusz Dyląg3, Aneta Nowakiewicz2.
Abstract
The European hedgehog (Erinaceus europaeus Linnaeus) frequently colonises areas located close to human life in cities, as these are more suitable nest sites offering an abundance of food and allowing avoidance of predators. However, urbanisation has a significant impact on the epidemiology of infectious diseases, including dermatophytoses, the primary source of which are wild animals. In this study, we determined the spectrum of dermatophytes isolated from the European hedgehog and assessed their susceptibility profile to antifungal drugs. Symptomatic and asymptomatic dermatophyte infections were observed in 7.7% and 8% of the 182 examined free-living hedgehogs, respectively. In the pool of the isolated dermatophyte strains, Trichophyton erinacei was dominant (29.9%), followed by Trichophyton mentagrophytes (17.9%), Trichophyton benhamiae (13.4%), Nannizzia gypsea (11.9%), Microsporum canis (10.4%), Nannizzia nana (7.5%), Paraphyton cookei (6.0%), and Nannizzia fulva (3.0%). Susceptibility tests revealed the highest activity of luliconazole and the lowest of activity fluconazole among the azole drugs applied. Although terbinafine generally exhibited high efficacy, two Trichophyton mentagrophytes isolates showed resistance to this drug (MIC = 2 µg/ml) resulting from missense mutations in the SQLE gene corresponding to the amino acid substitution Leu393Phe. Summarising, our study has also revealed that such wildlife animals as hedgehogs can be a reservoir of pathogenic human dermatophytes, including harmful strains resistant to commonly used antifungal drugs.Entities:
Keywords: Dermatophyte reservoir; Erinaceus europaeus; Prevalence; Urban areas; Wildlife; Zoonoses
Mesh:
Substances:
Year: 2021 PMID: 34536095 PMCID: PMC9436838 DOI: 10.1007/s00248-021-01866-w
Source DB: PubMed Journal: Microb Ecol ISSN: 0095-3628 Impact factor: 4.192
Fig. 1Free-living hedgehog (Erinaceus europaeus Linnaeus) during clinical examination in urbanised areas. Asymptomatic animal (A) and hedgehog with multiple lesions (B)
Numerical data on the number of tested hedgehogs and the results obtained
| Year | Number of samples | Number of isolates (%) | ||
|---|---|---|---|---|
| Asymptomatic | Symptomatic | Total | ||
| 2016 | 28 | 6 | 34 | 13 (38.2) |
| 2017 | 35 | 5 | 40 | 10 (25.6) |
| 2018 | 26 | 15 | 41 | 19 (46.3) |
| 2019 | 21 | 3 | 24 | 9 (39.1) |
| 2020 | 38 | 5 | 43 | 14 (32.5) |
| Summarized | 148 | 34 | 182 | 67 (36.8) |
Fig. 2Direct preparation from hedgehog skin scrapings stained with chlorazol black E magnified 400 × (Olympus BX51, Tokyo, Japan). Notes: A, arthrospores in the skin scrap; B, mycelium fragments indicated by arrows
Fig. 3Macro- and micromorphology of dermatophytes isolated from free-living hedgehogs. Notes: fungi cultured on Sabouraud medium at 28 °C for 21 days. A–D, Trichophyton mentagrophytes; E–H, Trichophyton benhamiae; I–L, Microsporum canis; M–P, Trichophyton erinacei. A, E, I, and M, obverse appearance; B, F, J, and N, reverse appearance; C, G, K, and O, micromorphology after staining with chlorazol black E at 400 × magnification (Olympus BX51, Tokyo, Japan); D, H, L, and P, micromorphology after staining with chlorazol black E at 1000 × magnification (Olympus BX51, Tokyo, Japan). 3B Macro- and micromorphology of dermatophytes isolated from free-living hedgehogs continued. Notes: fungi cultured on Sabouraud medium at 28 °C for 21 days. A–D, Nannizzia gypsea; E–H, Paraphyton cookei; I–L, Nannizzia nana; M–P, Nannizzia fulva; A, E, I, and M, obverse appearance; B, F, J, and N, reverse appearance; C, G, K, and O, micromorphology after staining with chlorazol black E at 400 × magnification (Olympus BX51, Tokyo, Japan); D, H, L, and P, micromorphology after staining with chlorazol black E at 1000 × magnification (Olympus BX51, Tokyo, Japan)
Diagnostic effectiveness of qPCR, direct microscopy, and culture methods in relation to clinical material
taken from hedgehogs
| Type of infection | Method [% of positive results] | ||||
|---|---|---|---|---|---|
| qPCR | Direct analysis | Cultures | |||
| In light microscopy | In fluorescence microscopy | Less than 10 colonies | More than 10 colonies | ||
| Symptomatic | 100 | 100 | 100 | 64.7 | 35.3 |
| Asymptomatic | 45.3 | 33.8 | 37.8 | 18.9 | 3.4 |
Dermatophyte species isolated from hedgehogs with the GenBank accession numbers of the nucleotide sequences
| Dermatophyte species | Type of infection | Number of isolates | GenBank accession numbers of ITS region and SQLE gene nucleotide sequences | |
|---|---|---|---|---|
| No | Total (%) | |||
| Symptomatic | 12 | 20 (29.9) | MW755314-MW755325 | |
| Asymptomatic | 8 | MW755306-MW755313 | ||
| Symptomatic | 8 | 12 (17.9) | MW759405-MW759412 SQLE (2 strains): MZ065195-MZ065196 | |
| Asymptomatic | 4 | MW759878-MW759881 | ||
| Symptomatic | 5 | 9 (13.4) | MW759866-MW759870 | |
| Asymptomatic | 4 | MW759871-MW759874 | ||
| Symptomatic | 4 | 7 (10.4) | MW759862-MW759865 | |
| Asymptomatic | 3 | MW759875-MW759877 | ||
| Symptomatic | 3 | 8 (11.9) | MW759402-MW759404 | |
| Asymptomatic | 5 | MW759413-MW759417 | ||
| Asymptomatic | 5 | 5 (7.5) | MW755440-MW755444 | |
| Symptomatic | 2 | 2 (3.0) | MZ052087-MZ052088 | |
| Asymptomatic | 4 | 4 (6.0) | MW755326-MW755329 | |
In vitro antifungal susceptibilities of dermatophyte isolates obtained from hedgehogs
| Antifungal agents | MIC (µg/ml) | Dermatophyte species | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Allylamine | NFT | MIC50 | 0.016 | 0.008 | 0.004 | 0.032 | 0.25 | 0.032 | 0.25 | 0.032 | |
| MIC90 | 0.032 | 0.016 | 0.016 | 0.064 | 0.25 | 0.032 | 0.5 | ||||
| TRB | MIC50 | 0.004 | 0.008 | (2) | 0.008 | 0.016 | 0.0125 | 0.032 | 0.0125 | 0.032 | |
| MIC90 | 0.0016 | 2 | 0.032 | 0.016 | 0.25 | 0.064 | 0.032 | ||||
| Polyenes | AMB | MIC50 | 0.25 | 0.25 | 0.125 | 0.25 | 0.064 | 0.125 | 0.25 | 0.5 | |
| MIC90 | 0.25 | 0.5 | 0.25 | 1 | 0.25 | 0.5 | 0.5 | ||||
| Non-polyenes | GRE | MIC50 | 1 | 1 | 0.5 | 0.25 | 0.5 | 0.25 | 1 | 0.5 | |
| MIC90 | 1 | 2 | 1 | 1 | 0.5 | 1 | 2 | ||||
| Imidazoles | KTC | MIC50 | 0.5 | 0.5 | 0.25 | 0.125 | 0.125 | 1 | 0.5 | 0.5 | |
| MIC90 | 0.5 | 2 | 0.5 | 0.5 | 0.125 | 1 | 1 | ||||
| MCZ | MIC50 | 0.032 | 0.064 | 0.016 | 0.032 | 0.064 | 0.5 | 0.125 | 0.064 | ||
| MIC90 | 0.125 | 0.125 | 0.125 | 0.064 | 0.125 | 2 | 0.25 | ||||
| ENC | MIC50 | 0.125 | 0.25 | 0.064 | 0.032 | 0.5 | 0.5 | 0.25 | 0.032 | ||
| MIC90 | 0.25 | 2 | 0.25 | 0.125 | 1 | 0.5 | 1 | ||||
| LUC | MIC50 | 0.004 | 0.004 | 0.016 | 0.008 | 0.016 | 0.008 | 0.016 | 0.008 | ||
| MIC90 | 0.016 | 0.008 | 0.032 | 0.016 | 0.064 | 0.064 | 0.016 | ||||
| Triazoles | ITC | MIC50 | 0.25 | 0.5 | 0.125 | 0.125 | 0.25 | 0.125 | 0.25 | 0.25 | |
| MIC90 | 1 | 2 | 0.25 | 1 | 0.5 | 1 | 1 | ||||
| FLC | MIC50 | 16 | 32 | 16 | 16 | 8 | 4 | 8 | 64 | ||
| MIC90 | 32 | 64 | 64 | 16 | 16 | 16 | 32 | ||||
| VRC | MIC50 | 0.032 | 0.016 | 0.032 | 0.064 | 0.016 | 0.125 | 0.25 | 0.125 | ||
| MIC90 | 0.125 | 0.064 | 0.25 | 0.125 | 0.064 | 0.5 | 1 | ||||
| Pyridinone derivatives | CPO | MIC50 | 0.064 | 0.016 | 0.032 | 0.25 | 0.016 | 0.032 | 0.064 | 0.032 | |
| MIC90 | 0.064 | 0.032 | 0.064 | 0.5 | 0.064 | 0.032 | 0.064 | ||||
| Phenyl morpholine derivatives | AMR | MIC50 | 0.008 | 0.016 | 0.008 | 0.016 | 0.032 | 0.008 | 0.016 | 0.016 | |
| MIC90 | 0.016 | 0.064 | 0.008 | 0.032 | 0.032 | 0.008 | 0.016 | ||||
Notes: abbreviations of antifungal substances: AMB, amphotericin B; AMR, amorolfine; CPO, ciclopirox; ENC, enilconazole; FLC, fluconazole; GRE, griseofulvin; ITC, itraconazole; KTC, ketoconazole; LUC, luliconazole; MCZ, miconazole; NFT, naftifine; TRB, terbinafine; VRC, voriconazole; (n), number of strains that showed resistance to terbinafine (MIC = 2 µg/ml); STstatistically significantly the lowest result in human/animals group; *the result presented for the two obtained isolates